Home Allozyne

Allozyne

acquired
Debt Financing
A Biotechnology Company
Basic
Enterprise Profile

Basic Information

Allozyne provides protein therapeutic product candidates for the treatment of autoimmune and inflammatory diseases and cancer. The company's developed technology can enhance the efficacy, safety, dosage, and other characteristics of protein therapies.
Allozyne, Inc.
Seattle,Washington,United States of America
15~50 people
January 01, 2005
info@allozyne.com

Enterprise Profile

Industrial Sector
New Drug Development